Sort by
Refine Your Search
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
nationalities represented in a student body of 43,800 students. Our main location in Central London has recently been augmented by a campus on the Queen Elizabeth Olympic Park. The UCL Faculty of Engineering is
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us UCL Biochemical Engineering (UCL-BE) is a world leader in bioprocessing, where researchers harness cutting-edge facilities and industry partnerships to transform breakthroughs in biology
-
About us The Faculty of Life Sciences (FLS) at UCL combines the strengths of UCL's basic biological and preclinical sciences and is associated with 11 Nobel Laureates. Research in FLS focuses
-
About us UCL Biochemical Engineering (UCL-BE) is a world leader in bioprocessing, where researchers harness cutting-edge facilities and industry partnerships to transform breakthroughs in biology
-
About us UCL Biochemical Engineering (UCL-BE) is a world leader in bioprocessing, where researchers harness cutting-edge facilities and industry partnerships to transform breakthroughs in biology